Viewing Study NCT07123168


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2025-12-26 @ 5:04 PM
Study NCT ID: NCT07123168
Status: COMPLETED
Last Update Posted: 2025-08-14
First Post: 2025-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hierarchical Management for Maintenance Hemodialysis Patients
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D007676', 'term': 'Kidney Failure, Chronic'}], 'ancestors': [{'id': 'D051436', 'term': 'Renal Insufficiency, Chronic'}, {'id': 'D051437', 'term': 'Renal Insufficiency'}, {'id': 'D007674', 'term': 'Kidney Diseases'}, {'id': 'D014570', 'term': 'Urologic Diseases'}, {'id': 'D052776', 'term': 'Female Urogenital Diseases'}, {'id': 'D005261', 'term': 'Female Urogenital Diseases and Pregnancy Complications'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D052801', 'term': 'Male Urogenital Diseases'}, {'id': 'D002908', 'term': 'Chronic Disease'}, {'id': 'D020969', 'term': 'Disease Attributes'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 80}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2024-01-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-08', 'completionDateStruct': {'date': '2024-11-30', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2025-08-08', 'studyFirstSubmitDate': '2025-08-08', 'studyFirstSubmitQcDate': '2025-08-08', 'lastUpdatePostDateStruct': {'date': '2025-08-14', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2025-08-14', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-11-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change in Quality of Life (QoL)', 'timeFrame': 'Baseline, 24 Weeks', 'description': 'Measured using the Mandarin Chinese version of the Kidney Disease Quality of Life-Short Form (KDQOL-SF™ 1.3). The instrument assesses both kidney disease-targeted areas (KDTA) and generic health (SF-36). Scores for each domain are transformed to a 0-100 scale, with higher scores indicating better quality of life.'}], 'secondaryOutcomes': [{'measure': 'Change in Disease-Related Knowledge', 'timeFrame': 'Baseline, 24 Weeks', 'description': 'Measured using the 24-item Hemodialysis Knowledge Questionnaire. The total score ranges from 0 to 24, with higher scores indicating greater knowledge.'}, {'measure': 'Change in Self-Management Ability', 'timeFrame': 'Baseline, 24 Weeks', 'description': 'Measured using the 20-item Hemodialysis Self-Management Instrument (HD-SMI). The total score ranges from 20 to 80, with higher scores reflecting better self-management ability.'}, {'measure': 'Change in Treatment Adherence', 'timeFrame': 'Baseline, 24 Weeks', 'description': 'Measured using the 23-item Treatment Adherence Scale for Hemodialysis Patients. The total score ranges from 23 to 115, with higher scores indicating better adherence.'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['End-stage Renal Disease (ESRD)']}, 'descriptionModule': {'briefSummary': "This prospective, randomized controlled trial investigates the effectiveness of a nurse-led, Triangle Hierarchical Management model compared to routine care for patients on maintenance hemodialysis. The study aims to determine if this risk-stratified management approach improves patients' quality of life, disease-related knowledge, self-management capabilities, and treatment adherence over a 24-week period.", 'detailedDescription': 'Patients undergoing maintenance hemodialysis (MHD) face significant disease burdens, leading to poor quality of life and suboptimal self-management. Conventional nursing care often lacks individualized strategies. The "Triangle" model of chronic care management, which stratifies patients into high-, medium-, and low-risk tiers, allows for targeted allocation of healthcare resources and education. This study adapted this model for an MHD population through a Delphi consultation with experts. Eighty patients were randomized to either receive the Triangle Hierarchical Management intervention or routine care for 24 weeks. The intervention group received tailored nursing support based on their risk level, which was re-assessed weekly. The study\'s objective is to provide evidence on whether this structured, risk-based nursing model is superior to standard care in improving key patient-reported outcomes for the MHD population in China.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Age ≥ 18 years.\n* Diagnosed with uremia and receiving maintenance hemodialysis for ≥ 6 months.\n* Willing to participate and provide written informed consent.\n\nExclusion Criteria:\n\n* Presence of severe psychiatric, intellectual, or cognitive impairments.\n* Diagnosis of severe cardiac, pulmonary, hepatic, or hematologic diseases or malignant tumors.\n* Presence of a severe active infection.\n* Concurrent participation in another clinical trial.'}, 'identificationModule': {'nctId': 'NCT07123168', 'briefTitle': 'Hierarchical Management for Maintenance Hemodialysis Patients', 'organization': {'class': 'OTHER', 'fullName': 'Shiyan Xiyuan Hospital'}, 'officialTitle': 'Effect of a Nurse-Led, Triangle-Based Hierarchical Management Model on Quality of Life, Disease-Related Knowledge, Self-Management, and Treatment Adherence in Patients Undergoing Maintenance Hemodialysis: A Randomized Controlled Trial', 'orgStudyIdInfo': {'id': 'surmyy2023-039'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Experimental: Observation Group (Triangle Hierarchical Management)', 'description': 'Participants received care based on a nurse-led, Triangle Hierarchical Management model for 24 weeks. Upon enrollment, patients were stratified into high-, medium-, or low-risk tiers based on clinical, functional, and psychological criteria. Management strategies, including nurse-to-patient ratios, health education intensity, and psychological support, were tailored to the risk tier. Patients were re-evaluated weekly, and their risk classification and management plan were adjusted accordingly.', 'interventionNames': ['Behavioral: Triangle Hierarchical Management']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Active Comparator: Control Group (Routine Care)', 'description': 'Participants received routine nursing care for 24 weeks. This included standard monitoring of laboratory parameters and vital signs, vascular access assessment, and one general health education session per month for patients and/or their families.', 'interventionNames': ['Behavioral: routine care']}], 'interventions': [{'name': 'Triangle Hierarchical Management', 'type': 'BEHAVIORAL', 'description': 'A nurse-led, risk-stratified management model where patients are categorized into high-, medium-, or low-risk tiers. High-risk patients receive intensive professional care (90%) and minimal self-management education (10%); medium-risk patients receive a balanced approach (50% each); and low-risk patients focus on self-management education (90%) with minimal professional care (10%). The intervention is delivered by trained nurses over 24 weeks.', 'armGroupLabels': ['Experimental: Observation Group (Triangle Hierarchical Management)']}, {'name': 'routine care', 'type': 'BEHAVIORAL', 'description': 'Standard nursing management for hemodialysis patients, including monthly monitoring, routine assessments, and general health education sessions. This care does not involve risk stratification or tailored interventions.', 'armGroupLabels': ['Active Comparator: Control Group (Routine Care)']}]}, 'contactsLocationsModule': {'locations': [{'zip': '442099', 'city': 'Shiyan', 'state': 'Hubei', 'country': 'China', 'facility': 'Renmin Hospital, Hubei University of Medicine', 'geoPoint': {'lat': 32.6475, 'lon': 110.77806}}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Yanyan Deng', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR_INVESTIGATOR', 'investigatorTitle': 'Principal investigator', 'investigatorFullName': 'Yanyan Deng', 'investigatorAffiliation': 'Shiyan Xiyuan Hospital'}}}}